New York State Common Retirement Fund’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.4M | Buy |
148,152
+22,945
| +18% | +$2.07M | 0.02% | 553 |
|
|
2026
Q1 | $10.9M | Buy |
125,207
+31,530
| +34% | +$3.07M | 0.02% | 683 |
|
|
2025
Q4 | $10M | Buy |
93,677
+18,546
| +25% | +$1.97M | 0.01% | 731 |
|
|
2025
Q3 | $7.59M | Buy |
75,131
+16,513
| +28% | +$1.53M | 0.01% | 875 |
|
|
2025
Q2 | $3.7M | Buy |
58,618
+41,768
| +248% | +$2.56M | ﹤0.01% | 1186 |
|
|
2025
Q1 | $893K | Hold |
16,850
| – | – | ﹤0.01% | 1679 |
|
|
2024
Q4 | $943K | Hold |
16,850
| – | – | ﹤0.01% | 1697 |
|
|
2024
Q3 | $883K | Sell |
16,850
-16,005
| -49% | -$767K | ﹤0.01% | 1727 |
|
|
2024
Q2 | $1.35M | Buy |
32,855
+44
| +0.1% | +$1.76K | ﹤0.01% | 1626 |
|
|
2024
Q1 | $1.42M | Sell |
32,811
-63
| -0.2% | -$2.76K | ﹤0.01% | 1605 |
|
|
2023
Q4 | $1.51M | Buy |
32,874
+12,233
| +59% | +$386K | ﹤0.01% | 1589 |
|
|
2023
Q3 | $473K | Buy |
20,641
+541
| +3% | +$12.1K | ﹤0.01% | 2075 |
|
|
2023
Q2 | $331K | Buy |
20,100
+19,028
| +1,775% | +$343K | ﹤0.01% | 2280 |
|
|
2023
Q1 | $19.1K | Hold |
1,072
| – | – | ﹤0.01% | 3134 |
|
|
2022
Q4 | $31.2K | Hold |
1,072
| – | – | ﹤0.01% | 3143 |
|
|
2022
Q3 | $26K | Buy |
1,072
+758
| +241% | +$14.1K | ﹤0.01% | 3211 |
|
|
2022
Q2 | $1K | Sell |
314
-30,268
| -99% | -$166K | ﹤0.01% | 3401 |
|
|
2022
Q1 | $352K | Buy |
30,582
+6
| +0% | +$53 | ﹤0.01% | 2564 |
|
|
2021
Q4 | $305K | Sell |
30,576
-4,589
| -13% | -$51.6K | ﹤0.01% | 2702 |
|
|
2021
Q3 | $459K | Sell |
35,165
-4,942
| -12% | -$75.5K | ﹤0.01% | 2513 |
|
|
2021
Q2 | $785K | Buy |
40,107
+5,102
| +15% | +$106K | ﹤0.01% | 2340 |
|
|
2021
Q1 | $745K | Buy |
35,005
+4,000
| +13% | +$116K | ﹤0.01% | 2259 |
|
|
2020
Q4 | $922K | Sell |
31,005
-2,300
| -7% | -$58.5K | ﹤0.01% | 2074 |
|
|
2020
Q3 | $722K | Hold |
33,305
| – | – | ﹤0.01% | 2050 |
|
|
2020
Q2 | $743K | Buy |
33,305
+4,000
| +14% | +$78K | ﹤0.01% | 2025 |
|
|
2020
Q1 | $446K | Buy |
29,305
+5,800
| +25% | +$104K | ﹤0.01% | 2102 |
|
|
2019
Q4 | $540K | Hold |
23,505
| – | – | ﹤0.01% | 2261 |
|
|
2019
Q3 | $507K | Hold |
23,505
| – | – | ﹤0.01% | 2329 |
|
|
2019
Q2 | $517K | Buy |
23,505
+6,400
| +37% | +$162K | ﹤0.01% | 2366 |
|
|
2019
Q1 | $469K | Hold |
17,105
| – | – | ﹤0.01% | 2342 |
|
|
2018
Q4 | $460K | Buy |
17,105
+3,500
| +26% | +$96.7K | ﹤0.01% | 2323 |
|
|
2018
Q3 | $397K | Hold |
13,605
| – | – | ﹤0.01% | 2519 |
|
|
2018
Q2 | $425K | Buy |
13,605
+5,400
| +66% | +$148K | ﹤0.01% | 2519 |
|
|
2018
Q1 | $163K | Buy |
8,205
+1,005
| +14% | +$26.7K | ﹤0.01% | 2818 |
|
|
2017
Q4 | $209K | Buy |
+7,200
| New | +$190K | ﹤0.01% | 2741 |
|
Other funds holding RYTM
AL
WCM
KOCAA
PFSRSONJ
CUAMC
New York State Common Retirement Fund's RYTM Position: Q2 2026 in Review
New York State Common Retirement Fund increased its Rhythm Pharmaceuticals (RYTM) stake by 18% in Q2 2026, buying an estimated $2.07M and bringing the position to 148,152 shares worth $16.4M. The position accounts for 0.02% of the portfolio, ranked #553.
New York State Common Retirement Fund first reported a position in RYTM in Q4 2017 and has held it in 35 quarters since. 57 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.
- New York State Common Retirement Fund held 148,152 shares of Rhythm Pharmaceuticals worth $16.4M as of Q2 2026.
- New York State Common Retirement Fund bought 22,945 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $2.07M.
- Rhythm Pharmaceuticals made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #553 holding.
- New York State Common Retirement Fund first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
- 57 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.